EDGAR Filing Documents for 0001206774-10-000298

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001206774-10-000298

Filing Date

2010-02-18

Accepted

2010-02-18 08:30:41

Documents

Period of Report

2009-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	ANNUAL REPORT	regeneron_10k.htm	10-K	1518901
2	AMENDED AND RESTATED DISCOVERY AND PRECLINICAL DEVELOPMENT AGREEMENT	exhibit10-14.htm	EX-10.14	416289
3	AMENDED AND RESTATED LICENSE AND COLLABORATION AGREEMENT	exhibit10-15.htm	EX-10.15	724447
4	FIRST AMENDMENT TO THE DECEMBER 20, 2007 INVESTOR AGREEMENT	exhibit10-17_1.htm	EX-10.17.1	23003
5	CONSENT OF PRICEWATERHOUSECOOPERS LLP	exhibit23-1.htm	EX-23.1	2583
6	CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)	exhibit31-1.htm	EX-31.1	11230
7	CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)	exhibit31-2.htm	EX-31.2	11948
8	CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350	exhibit32.htm	EX-32	5115
9		regeneron_10k4x4x1.jpg	GRAPHIC	47728
	Complete submission text file	0001206774-10-000298.txt		2780720

Mailing Address

Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000

REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)